GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » ROE %

Mentor Capital (Mentor Capital) ROE % : 529.76% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Mentor Capital ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Mentor Capital's annualized net income for the quarter that ended in Dec. 2023 was $14.04 Mil. Mentor Capital's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $2.65 Mil. Therefore, Mentor Capital's annualized ROE % for the quarter that ended in Dec. 2023 was 529.76%.

The historical rank and industry rank for Mentor Capital's ROE % or its related term are showing as below:

MNTR' s ROE % Range Over the Past 10 Years
Min: -69.89   Med: -22.17   Max: 153.32
Current: 153.32

During the past 11 years, Mentor Capital's highest ROE % was 153.32%. The lowest was -69.89%. And the median was -22.17%.

MNTR's ROE % is ranked better than
98.45% of 772 companies
in the Capital Markets industry
Industry Median: 5.34 vs MNTR: 153.32

Mentor Capital ROE % Historical Data

The historical data trend for Mentor Capital's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mentor Capital ROE % Chart

Mentor Capital Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -69.89 -25.60 -11.68 -23.89 111.61

Mentor Capital Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.92 -11.41 -31.69 -46.96 529.76

Competitive Comparison of Mentor Capital's ROE %

For the Capital Markets subindustry, Mentor Capital's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mentor Capital's ROE % Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Mentor Capital's ROE % distribution charts can be found below:

* The bar in red indicates where Mentor Capital's ROE % falls into.



Mentor Capital ROE % Calculation

Mentor Capital's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=3.158/( (1.743+3.916)/ 2 )
=3.158/2.8295
=111.61 %

Mentor Capital's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=14.036/( (1.383+3.916)/ 2 )
=14.036/2.6495
=529.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Mentor Capital  (OTCPK:MNTR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=14.036/2.6495
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(14.036 / -25.732)*(-25.732 / 4.8085)*(4.8085 / 2.6495)
=Net Margin %*Asset Turnover*Equity Multiplier
=-54.55 %*-5.3514*1.8149
=ROA %*Equity Multiplier
=291.92 %*1.8149
=529.76 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=14.036/2.6495
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (14.036 / 13.484) * (13.484 / -6.076) * (-6.076 / -25.732) * (-25.732 / 4.8085) * (4.8085 / 2.6495)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0409 * -2.2192 * 23.61 % * -5.3514 * 1.8149
=529.76 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Mentor Capital ROE % Related Terms

Thank you for viewing the detailed overview of Mentor Capital's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mentor Capital (Mentor Capital) Business Description

Traded in Other Exchanges
N/A
Address
5964 Campus Court, Plano, TX, USA, 75093
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely the historic cannabis and medical marijuana segment, and the Company's legacy investment in WCI, which works with business park owners, governmental centers, and apartment complexes to reduce their facility-related operating costs. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, and Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Executives
David G. Carlile director 10901 BULLRUSH DRIVE, VENICE FL 34293
Lori Stansfield officer: Chief Financial Officer 903 N. TOWNER STREET, SANTA ANA CA 92703
Chester Billingsley director, 10 percent owner, officer: Chief Executive Officer 5964 CAMPUS COURT, PLANO TX 75093
Stan Shaul director 2586 CLAYBOURNE COURT, NEWBURY PARK CA 91320
Robert Bernhard Meyer director 24446 CASWELL COURT, LAGUNA NIGUEL CA 92677
Earl Kornbrekke director 458 DEHARO LANE, FRIDAY HARBOR WA 98250
James Blazeck director 536 OVERLOOK DRIVE, PITTSBURG PA 15216